NCT01791205View on ClinicalTrials.gov

ARMONIA: An Observational Study of Biologic Drugs in Monotherapy or Combination With DMARDs in Italian Clinical Practice and the Efficacy and Safety of RoActemra/Actemra (Tocilizumab) Monotherapy in Patients With Rheumatoid Arthritis

CompletedOBSERVATIONAL
Enrollment

304

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Rheumatoid Arthritis
Trial Locations (28)

10126

Turin

10128

Turin

20025

Legnano

20052

Monza

20157

Milan

20162

Milan

27100

Pavia

35128

Padua

37126

Verona

40138

Bologna

44124

Cona (Ferrara)

50139

Florence

53100

Siena

56100

Pisa

59100

Prato

60020

Ancona

60035

Iesi

70124

Bari

74015

Martina Franca

80131

Napoli

82037

Telese Terme

89133

Reggio Calabria

00133

Rome

00152

Rome

00161

Rome

00189

Rome

07100

Sassari

06122

Perugia

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01791205 - ARMONIA: An Observational Study of Biologic Drugs in Monotherapy or Combination With DMARDs in Italian Clinical Practice and the Efficacy and Safety of RoActemra/Actemra (Tocilizumab) Monotherapy in Patients With Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter